Novel furano analogues of duocarmycin C1 and C2: design, synthesis, and biological evaluation of seco-iso-Cyclopropylfurano[2,3-e]indoline (seco-iso-CFI) and seco-Cyclopropyltetrahydrofurano[2,3-f]quinoline (seco-CFQ) analogues

This publication has 43 references indexed in Scilit:

• Shape-Dependent Catalysis: Insights into the Source of Catalysis for the CC-1065 and Duocarmycin DNA Alkylation Reaction
  Accounts of Chemical Research, 1999
• CC‐1065 and the Duocarmycins: Understanding their Biological Function through Mechanistic Studies
  Angewandte Chemie International Edition in English, 1996
• Phase I trial of Adozelesin using the treatment schedule of daily × 5 every 3 weeks
  Investigational New Drugs, 1995
• CC-1065 and the duocarmycins: unraveling the keys to a new class of naturally derived DNA alkylating agents.
  Proceedings of the National Academy of Sciences, 1995
• The Duocarmycins: Synthetic and Mechanistic Studies
  Accounts of Chemical Research, 1995
• Phase I Study of Adozelesin Administered by 24-Hour Continuous Intravenous Infusion
  JNCI Journal of the National Cancer Institute, 1994
• Evaluation of the antineoplastic activity of Adozelesin alone and in combination with 5-aza-2-deoxycytidine and cytosine arabinoside on DLD-1 human colon carcinoma cells
  Anti-Cancer Drugs, 1993
• Comparison of U-73,975 and cisplatin cytotoxicity in fresh cervical and ovarian carcinoma specimens with the ATP-chemosensitivity assay
  Gynecologic Oncology, 1992
• Adozelesin, a selected lead among cyclopropylpyrroloindole analogs of the DNA-binding antibiotic, CC-1065
  Investigational New Drugs, 1991
• Structure and activity relationship of several novel CC-1065 analogs
  Investigational New Drugs, 1987